Who Exports Tenofovir from India — 296 Suppliers Behind a $4.3B Market
India's tenofovir export market is supplied by 296 active exporters who collectively shipped $4.3B across 7,518 shipments. MACLEODS PHARMACEUTICALS LTD leads with a 75.1% market share, followed by HETERO LABS LIMITED and MYLAN LABORATORIES LIMITED. The top 5 suppliers together control 95.3% of total export value, reflecting a concentrated market structure.
Top Tenofovir Exporters from India — Ranked by Export Value
MACLEODS PHARMACEUTICALS LTD is the leading tenofovir exporter from India, holding a 75.1% share of the $4.3B market across 7,518 shipments from 296 exporters. The top 5 suppliers — MACLEODS PHARMACEUTICALS LTD, HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED, EMCURE PHARMACEUTICALS LIMITED — collectively control 95.3% of total export value, indicating a highly concentrated market. Individual shares are: MACLEODS PHARMACEUTICALS LTD (75.1%), HETERO LABS LIMITED (13.6%), MYLAN LABORATORIES LIMITED (3.8%), STRIDES PHARMA SCIENCE LIMITED (1.4%), EMCURE PHARMACEUTICALS LIMITED (1.3%).
Top Tenofovir Exporters from India
Ranked by export value · 296 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRDOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR | $3.3B | 74 | 75.1% |
| 2 | HETERO LABS LIMITED DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRDOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR | $589.0M | 105 | 13.6% |
| 3 | MYLAN LABORATORIES LIMITED DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRDOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR | $165.9M | 111 | 3.8% |
| 4 | STRIDES PHARMA SCIENCE LIMITED DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,ATROIZA (75827 PACKS X 30S = 22DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR | $60.7M | 21 | 1.4% |
| 5 | EMCURE PHARMACEUTICALS LIMITED DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRATROIZA (75827 PACKS X 30S = 22ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE | $56.8M | 45 | 1.3% |
| 6 | CIPLA LIMITED DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRATROIZA (75827 PACKS X 30S = 22ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE | $52.1M | 44 | 1.2% |
| 7 | MACLEODS PHARMACEUTICALS LIMITED DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRDOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR | $43.5M | 43 | 1.0% |
| 8 | APL HEALTHCARE LIMITED DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIRATROIZA (75827 PACKS X 30S = 22 | $33.0M | 10 | 0.8% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRATROIZA (75827 PACKS X 30S = 22ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE | $12.8M | 15 | 0.3% |
| 10 | AUROBINDO PHARMA LTD ATROIZA (75827 PACKS X 30S = 22ACRIPTEGA TENOFOVIRDISOPROXILFUMARATEDOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLETS | $7.9M | 10 | 0.2% |
| 11 | BHARAT PARENTERALS LIMITED | $7.8M | 1 | 0.2% |
| 12 | LUPIN LIMITED TENOFOVIR EMTRICITAB TABLETTENOFOVIR DIS+EMTRICITAB TABLETTENOFOVIR DIS+EMTRICITAB 245MG+200MG TABLET | $7.2M | 4 | 0.2% |
| 13 | LAURUS LABS LTD DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET 90S,DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIRDOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DISOPR TABLET | $5.3M | 6 | 0.1% |
| 14 | EMCURE PHARMACEUTICALS LTD DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIRDISOPRATROIZA (75827 PACKS X 30S = 22ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE | $5.2M | 4 | 0.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Tenofovir exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Macleods Pharmaceuticals Ltd | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Hetero Labs Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Mylan Laboratories Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Strides Pharma Science Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Emcure Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant; received FDA warning letter i |
| Cipla Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Aurobindo Pharma Ltd | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Lupin Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
| Laurus Labs Ltd | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; EU GMP compliant. |
TransData Nexus reviewed the regulatory standing of 10 leading Tenofovir exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Tenofovir sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, along with advanced R&D infrastructure and institutions like the National Institute of Pharmaceutical Education and Research (NIPER), positions Hyderabad as a key player in API manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to major companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's robust infrastructure, including well-developed ports and transportation networks, facilitates efficient production and distribution of pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, hosts numerous pharmaceutical companies and provides access to major ports, enabling seamless export operations. The region's strategic location and well-established logistics infrastructure make it a vital hub for pharmaceutical exports.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, has emerged as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth is attributed to favorable government policies, including tax incentives and exemptions, which have attracted numerous pharmaceutical companies. Baddi's strategic location and robust infrastructure further enhance its appeal as a manufacturing destination.
5Sourcing Recommendations
- Diversify Supplier Base: While MACLEODS PHARMACEUTICALS LTD dominates Tenofovir exports, consider engaging with other manufacturers such as HETERO LABS LIMITED and MYLAN LABORATORIES LIMITED to mitigate supply chain risks.
- Leverage Regional Specializations: Utilize Hyderabad's expertise in API production for sourcing raw materials and Ahmedabad-Vadodara's capabilities in formulations for finished products.
- Optimize Logistics: Capitalize on the Mumbai-Thane-Raigad region's export infrastructure to streamline international shipments and reduce lead times.
- Explore Cost Benefits: Investigate manufacturing opportunities in Baddi-Nalagarh to take advantage of tax incentives and cost-effective production facilities.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can enhance its supply chain resilience and optimize sourcing strategies for Tenofovir.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Tenofovir exporters from India
Strides Pharma Science Limited — Strides acquires New York manufacturing facility
Strides Pharma Science Limited announced the acquisition of a manufacturing facility in Chestnut Ridge, New York, enhancing its production capabilities in the United States.
Impact: This expansion is expected to bolster Strides' capacity to meet the growing demand for Tenofovir in the U.S. market.
Strides Pharma Science Limited — Strides launches OneSource, India's first specialty pharma CDMO
Strides Pharma Science Limited introduced OneSource, India's first specialty pharmaceutical Contract Development and Manufacturing Organization (CDMO), aiming to provide end-to-end solutions for pharmaceutical companies.
Impact: This initiative may lead to increased production efficiency and potentially lower costs for Tenofovir manufacturing.
Macleods Pharmaceuticals Limited — Macleods attends NACO's Tenofovir procurement meeting
Macleods Pharmaceuticals Limited participated in the National AIDS Control Organisation's (NACO) pre-bid meeting for the procurement of Tenofovir-based antiretroviral therapy, indicating active involvement in government tenders.
Impact: Engagement in such procurement processes may strengthen Macleods' position in supplying Tenofovir to national health programs.
Common Questions — Tenofovir Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which tenofovir supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MACLEODS PHARMACEUTICALS LTD leads with 519 recorded shipments worth $3.3B. HETERO LABS LIMITED (1,285 shipments) and MYLAN LABORATORIES LIMITED (1,002 shipments) are also established high-volume exporters.
Q How many tenofovir manufacturers are there in India?
India has 296 active tenofovir exporters with a combined export market of $4.3B across 7,518 shipments to 182 countries. The top 5 suppliers hold 95.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for tenofovir from India?
Average FOB unit price: $9.60 per unit, ranging from $0.00 to $9690.00. Average shipment value: $575.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 296 verified Indian exporters of Tenofovir ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 7,518 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 182 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7,518 Verified Shipments
296 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists